Primary malignant melanoma of the skin metastatic to the eye.
D000328:Adult; D001766:Blindness / Q000209:etiology; D005123:Eye / Q000473:pathology; D005134:Eye Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D005260:Female; D006801:Humans; D007249:Inflammation / Q000209:etiology; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009603:Nitroso Compounds / Q000009:adverse effects*; D009607:Nitrosourea Compounds / Q000009:adverse effects / Q000627:therapeutic use; D012163:Retinal Detachment / Q000209:etiology; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000473:pathology; D014508:Urea / Q000009:adverse effects*; D014750:Vincristine / Q000009:adverse effects*
D009603:Nitroso Compounds; D009607:Nitrosourea Compounds; D014750:Vincristine; D014508:Urea